{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:03:22Z","timestamp":1759104202991,"version":"3.44.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.jneuroim.2015.12.012","type":"journal-article","created":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T22:16:06Z","timestamp":1451427366000},"page":"78-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Autoantibodies to tetraspanins (CD9, CD81 and CD82) in demyelinating diseases"],"prefix":"10.1016","volume":"291","author":[{"given":"Kazuki","family":"Miyaji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedemann","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nortina","family":"Shahrizaila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thirugnanam","family":"Umapathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Yuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2015.12.012_bb0005","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain\u2013Barr\u00e9 syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/ana.21311","article-title":"Homogeneity of active demyelinating lesions in established multiple sclerosis","volume":"63","author":"Breij","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0015","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/jnr.23272","article-title":"Tetraspanins are involved in Schwann cell\u2013axon interaction","volume":"91","author":"Chernousov","year":"2013","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0020","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/archneur.1980.00500590061010","article-title":"Immunoglobulin and complement deposits in nerves of patients with chronic relapsing polyneuropathy","volume":"37","author":"Dalakas","year":"1980","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0025","first-page":"1","article-title":"A gene pathway analysis highlights the role of cellular adhesion molecules in multiple sclerosis susceptibility","volume":"2","author":"Damotte","year":"2014","journal-title":"Genes Immun."},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0030","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.4049\/jimmunol.177.8.5129","article-title":"Tetraspanins CD9 and CD81 modulate HIV-1-induced membrane fusion","volume":"177","author":"Gord\u00f3n-Alonso","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0035","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.410400414","article-title":"Acute motor axonal neuropathy: an antibody-mediated attack on axolemma","volume":"40","author":"Hafer-Macko","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0040","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.410390512","article-title":"Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy","volume":"39","author":"Hafer-Macko","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0045","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1074\/jbc.M112.424291","article-title":"Deletion of tetraspanin CD9 diminishes lymphangiogenesis in vivo and in vitro","volume":"288","author":"Iwasaki","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0050","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-9-14","article-title":"Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients","volume":"9","author":"Jarius","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0055","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/cei.12271","article-title":"Neuromyelitis optica: clinical features, immunopathogenesis and treatment","volume":"176","author":"Jarius","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0060","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/cen3.12007","article-title":"Pathogenic roles of antiganglioside antibodies in immune-mediated neuropathies","volume":"4","author":"Kaida","year":"2013","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0065","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0165-5728(93)90255-W","article-title":"Antibody responses to P0 and P2 myelin proteins in Guillain\u2013Barr\u00e9 syndrome and chronic idiopathic demyelinating polyradiculoneuropathy","volume":"46","author":"Khalili-Shirazi","year":"1993","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0070","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","article-title":"Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype","volume":"79","author":"Kitley","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0075","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1093\/brain\/awq260","article-title":"Conduction block in acute motor axonal neuropathy","volume":"133","author":"Kokubun","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0080","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMra041347","article-title":"Chronic inflammatory demyelinating polyneuropathy","volume":"352","author":"K\u00f6ller","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0085","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1084\/jem.20071053","article-title":"Neurofascin as a novel target for autoantibody-mediated axonal injury","volume":"204","author":"Mathey","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0090","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archneur.61.7.1097","article-title":"Immunolocalization and activation of transcription factor nuclear factor \u03baB in dysimmune neuropathies and familial amyloidotic polyneuropathy","volume":"61","author":"Mazzeo","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0095","doi-asserted-by":"crossref","first-page":"11172","DOI":"10.1523\/JNEUROSCI.3075-09.2009","article-title":"The tetraspanin KAI1\/CD82 is expressed by late-lineage oligodendrocyte precursors and may function to restrict precursor migration and promote oligodendrocyte differentiation and myelination","volume":"29","author":"Mela","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0100","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jneuroim.2014.08.004","article-title":"Complement regulatory proteins (CD46, 55 and 59) expressed on Schwann cells: immune targets in demyelinating neuropathies?","volume":"276","author":"Miyaji","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0105","doi-asserted-by":"crossref","first-page":"16369","DOI":"10.1523\/JNEUROSCI.4016-11.2011","article-title":"Quantitative and integrative proteome analysis of peripheral nerve myelin identifies novel myelin proteins and candidate neuropathy loci","volume":"31","author":"Patzig","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0110","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d","volume":"58","author":"Polman","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0115","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.23794","article-title":"Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy","volume":"73","author":"Querol","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0120","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/glia.22565","article-title":"Roles for HB-EGF and CD9 in multiple sclerosis","volume":"61","author":"Schenk","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0125","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1523\/JNEUROSCI.4401-06.2007","article-title":"Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers","volume":"27","author":"Susuki","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0130","doi-asserted-by":"crossref","first-page":"26089","DOI":"10.1074\/jbc.M801902200","article-title":"Double deficiency of tetraspanins CD9 and CD81 alters cell motility and protease production of macrophages and causes chronic obstructive pulmonary disease-like phenotype in mice","volume":"283","author":"Takeda","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0135","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/glia.10134","article-title":"The tetraspanin protein, CD9, is expressed by progenitor cells committed to oligodendrogenesis and is linked to \u03b21 integrin, CD81, and Tspan-2","volume":"40","author":"Terada","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0140","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1073\/pnas.0709619104","article-title":"Ganglioside GM2\/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82\/cMet-mediated pathway","volume":"105","author":"Todeschini","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0145","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"Van den Bergh","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0150","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0155","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2015.12.012_bb0160","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain\u2013Barr\u00e9 syndrome","volume":"366","author":"Yuki","year":"2012","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572815301065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572815301065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:27:19Z","timestamp":1759048039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572815301065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":32,"alternative-id":["S0165572815301065"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2015.12.012","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies to tetraspanins (CD9, CD81 and CD82) in demyelinating diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2015.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}